Morepen Laboratories Ltd
Jatinder Dhari is a seasoned pharmaceutical professional with over 18 years of experience in formulation research and development. Currently serving as Sr. Manager of Formulation R&D at Morepen Laboratories Limited India since April 2010, Jatinder is responsible for product development for both domestic and export markets, overseeing scale-up processes, reviewing technical documents, and managing a team of M. Pharm professionals. Prior to this role, Jatinder worked as a Sr. Research Scientist at Ind-Swift Limited from February 2005 to April 2010, where responsibilities included product development, stability studies, and preparation of dossiers. Jatinder holds an M.Pharm degree in Formulation Development from Manipal Academy of Higher Education, obtained between 2002 and 2004.
This person is not in any offices
Morepen Laboratories Ltd
Morepen Laboratories Limited is a pharmaceutical company. The Company's divisions include Active Pharmaceutical Ingredients (API), Home Diagnostics and Finished Formulations. The API division offers products, such as Loratadine Process-1, Desloratadine, Atorvastatin Calcium Amorphous, Atorvastatin Calcium Crystalline Form VI and Linagliptin, among others. The Company offers products under the self-health diagnostic brand HomeHealth. Its HomeHealth portfolio includes automatic digital blood pressure monitors, digital and analog weighing scales, body and foot massagers, heat therapy range, nebulizers, pregnancy cards, and clinical and digital thermometers. The Company offers no coding blood glucose monitoring system under its brand, GlucoOne. It markets various brands of medical devices and clinical diagnostic products. The Company operates in India, the United States and Rest of World. Its subsidiaries include Dr. Morepen Limited, Total Care Limited and Morepen Inc.